<DOC>
	<DOCNO>NCT02535104</DOCNO>
	<brief_summary>Ranpirnase topical formulation antiviral drug evaluate topical treatment anogenital wart . The aim study evaluate efficacy safety topical formulation ranpirnase subject genital wart .</brief_summary>
	<brief_title>Safety Efficacy Study Topical Ranpirnase Treat Genital Warts ( HPV )</brief_title>
	<detailed_description>The study consist evaluation 4 week exposure study product ; design randomize , double blind , vehicle study effect 1 mg/ml concentration ranpirnase anogenital wart . The dermal reaction score scale describes amount erythema , edema , feature indicative irritation . The clinical response score basis percentage reduction lesion size number .</detailed_description>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Ranpirnase</mesh_term>
	<criteria>Diagnosis external genital / perianal wart least 2 wart 30 lesion Accept follow study instruction / signature IC Abstain sexual intercourse 6 hour apply study product time study . Any topical and/or destructive treatment external genital wart within 4 week ( within 12 month imiquimod within 12 week sinecatechins ) prior enrollment ( i.e. , randomization visit ) Non pregnant . For woman reproductive age would require pregnancy test , use double barrier contraceptive . Any following condition : Known allergy study product Internal ( rectal , urethral ) wart require undergoing treatment ; A dermatological disease ( e.g. , psoriasis ) skin condition area , may interfere evaluation . Imiquimod 5 % cream ( AldaraÂ® ) Any market investigational HPV vaccine Sinecatechins ( Veregen ) Interferon interferon inducer Cytotoxic drug Immunomodulators immunosuppressives Oral parenteral corticosteroid ( inhaled/intranasal steroid permit ) Oral antiviral drug ( exception HAART , oral acyclovir acyclovir relate drug ) suppressive acute therapy herpes ; oseltamivir prophylaxis influenza ) Topical antiviral drug ( include topical acyclovir acyclovir relate drug ) area treatment Podophyllotoxin/Podofilox treatment area Any topical prescription medication treatment area Dermatologic procedures surgery treatment area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>